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ABSTRACT 
Context 
Understanding the prevalence and characteristics of primary care outpatients being at risk of 
deteriorating and dying may allow general practitioners (GPs) to identify them, and initiate 
end-of-life discussions. 
Objectives  
This study aimed to investigate the prevalence and characteristics of primary care outpatients 
being at risk of deteriorating and dying, as determined by the Supportive and Palliative Care 
Indicators Tool (SPICT™). 
Methods 
A multicenter cross-sectional observational study was conducted at 17 clinics with 22 GPs. We 
enrolled all patients aged ≥65 years who visited the GPs in March 2017. We used the Japanese 
version of the SPICT™ to identify patients being at risk of deteriorating and dying. We assessed 
the demographic and clinical characteristics of enrolled patients. 
Results 
In total, 382 patients with a mean age of 77.4 ± 7.9 years were investigated. Sixty-six patients 
(17.3%) had ≥2 positive general indicators or ≥1 positive disease-specific indicator in the 
SPICT-JP. Patients with dementia/frailty, neurological disease, cancer, and kidney disease 
showed a significantly elevated risk of deteriorating and dying, while patients with other 
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specific disease did not. The patients at risk were significantly older and less likely to be living 
with family at home. They also had a higher Charlson Comorbidity Index score and a lower 
Palliative Performance Scale score. 
Conclusion 
Among primary care outpatients aged over 65 years, 17.3% were at risk of deteriorating and 
dying regardless of their estimated survival time, and many outpatients at risk were not 
receiving optimal multidisciplinary care. 
 
 
Keywords: Identification tool, SPICT™, primary care, outpatients 
 
Running Title: Risk of deteriorating and dying in primary care 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
4 
 
Introduction 
Most patients with chronic illnesses are managed in primary care over a long period1. 
Appropriate identification of such patients who may be at risk of deteriorating and dying would 
allow general practitioners (GPs) to assess them and identify the unmet supportive and palliative 
care needs of these patients and their families2. 
Assessment of unmet supportive and palliative care needs could also lead to initiation of 
end-of-life discussions among patients, family members, and GPs, which is essential for 
high-quality end-of-life planning3–6, although GPs consider that they lack sufficient knowledge 
and skill to appropriately assess such unmet needs 7,8.  
A recent study demonstrated that use of a systematic method or tool could facilitate efficient 
identification of patients who may be at risk of deteriorating and dying9. Several methods or 
tools have been developed for use in the primary care setting10, such as the Gold Standards 
Framework Prognostic Indicator Guidance11, Supportive and Palliative Care Indicators Tool 
(SPICT™)12, Palliative Necessities CCOMS-ICO (NECPAL)13, and RADboud indicators for 
PAlliative Care Needs14. A recent systematic review found that the SPICT™ is the most suitable 
tool for introduction and adoption in various primary care clinical settings 15.  
The SPICT™ is designed to identify patients with chronic progressive diseases who are at risk 
of deteriorating and might benefit from palliative care. Unlike other methods or tools, the 
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SPICT is not restricted to specific diseases and has been tested in different settings (e.g. primary 
care, home care, and hospitals)12,16–18.  
Knowing the prevalence and characteristic of patients who may be at risk of deteriorating and 
dying in primary care should help GPs to identify such patients. Timely identification also could 
overcome the barriers to initiating end-of-life discussions8. Subsequently, GPs can organize 
appropriate care to achieve each patient’s care goals. 
Therefore, this multicenter observational study was performed to investigate the prevalence 
and characteristics of primary care outpatients who may be at risk of deteriorating and dying, as 
determined by the SPICT™. 
 
Methods 
This multicenter cross-sectional observational study was conducted at 17 clinics with 22 GPs in 
Japan. In March 2017, each clinic set an arbitrary day for each GP in advance and we enrolled 
the outpatients over 65 years old who were seen by those GPs on that day. This study was 
conducted in accordance with the ethical standards of the Declaration of Helsinki and the ethical 
guidelines for epidemiological research issued by the Ministry of Health, Labour and Welfare of 
Japan. The institutional review board of the University of Tsukuba approved this study 
(No.1089). 
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Supportive and Palliative Care Indicators Tool (SPICT™) 
The SPICT™ was originally developed in Scotland and was based on the American National 
Health Observances guideline for eligibility of patients for hospice care combined with a further 
literature review and expert consensus input19,20. The SPICT™ consist of a combination of 
general clinical indicators (e.g. poor performance status, unplanned hospital admissions, or 
persistent symptoms despite optimal treatment of the underlying condition) relevant to patients 
with any advanced illness and disease-specific indicators for common advanced conditions (e.g. 
cancer, dementia, and cardiac, pulmonary, or renal disease).  
The development, structure, and evaluation of the original English version of the SPICT™ have 
been described elsewhere12, as well as its use as a guide to help physicians recognize people at 
risk of deteriorating and dying17,18. 
 
Development of the Japanese version of SPICT™ 
The Japanese version of SPICT™ (SPICT-JP) was developed according to an international 
standard translation and back-translation procedure21. The English-language items were initially 
translated by two native Japanese speakers who had experience with community palliative care 
and knew how words and phrases would be understood by general practitioners in Japan. Then 
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the two translations were reconciled by discussion. Any disagreements and unclear points were 
recorded, and we sought clearer explanations from the developer of the original version. The 
synthesized version was back-translated by a professional Japanese translator and the 
appropriateness of the English expressions was subsequently checked by a native English 
speaker. Then an independent professional proof-reader compared the completed synthesized 
version and the back translation, and provided comments. Subsequently, an expert panel with 
nine members (general practitioners with or without a special interest in palliative care, home 
care physicians, and palliative care physicians) reviewed the synthesized version. The final 
version of the SPICT-JP was developed by incorporating the comments of the expert panel. 
 
Data collection 
We recorded demographic and clinical characteristics of the patients, including the age, sex, 
living situation, main underlying disease, use of care services, and level of care needed22. We 
assessed the Charlson Comorbidity Index (CCI) score23, the Palliative Performance Scale (PPS), 
and the 6 general clinical indicators and 25 disease-specific indicators in the SPICT-JP. 
(Appendix 1). 
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Statistical analysis 
According to previous reports24, we defined patients as being at risk of deteriorating and dying 
if they had ≥2 positive general indicators or ≥1 positive disease-specific indicators in the 
SPICT-JP. We calculated descriptive statistics for the prevalence of patients being at risk of 
deteriorating and dying. Characteristics of the participants were described as proportions for 
categorical variables and were analyzed by Pearson’s χ2 test or Fisher’s exact test, while 
continuous variables were analyzed by Student’s t-test. In all statistical evaluations, a P value of 
less than 0.05 was considered significant. Analyses were conducted with SPSS-J software 
(version 24.0; IBM, Tokyo, Japan). 
 
Results 
A total of 382 patients were included in this study and their characteristics are summarized in 
Table 1. The mean age was 77.4 ± 7.9 years. Most of the patients lived at home with their 
families (78.0%), had a CCI score of zero (78.8%), PPS≥80 (79.1%), no certified care needs 
(75.9%), and no use of care services (81.4%). The most common main underlying disease was 
hypertension (31.9%), followed by dementia/frailty (15.2%) and cardiovascular disease 
excluding hypertension (9.2%). Only 2 patients (0.5%) used a specialized palliative care service. 
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Prevalence of patients being at risk of deteriorating and dying (Table 2) 
 The most common general indicator for a higher risk of deteriorating and dying was “The 
person or family asked for palliative care, treatment withdrawal/limitation, or a focus on quality 
of life” (25.4%). The major clinical indicator was “No longer able to communicate using verbal 
language; little social interaction” (n=23), followed by “Urinary and fecal incontinence” (n=13) 
and “Unable to dress, walk or eat without help” (n=12) in patients with dementia/frailty. 
 
Characteristics of patients being at risk of deteriorating and dying (Table 3) 
 The characteristics of the patients being at risk of deteriorating and dying are shown in Table 3. 
Sixty-six patients (17.3%) had ≥2 positive general indicators or ≥1 positive disease-specific 
indicator. Patients with dementia/frailty, neurological disease, cancer, and kidney disease had a 
significantly higher risk of deteriorating and dying, while patients with other specific diseases 
did not. The patients at risk were significantly older than those not at risk, were less likely to be 
living at home with family members, and had higher CCI scores and a lower PPS. The care 
services used by patients at risk were mainly home nursing, home help service, and day care/day 
service.  
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Discussion 
To our knowledge, this is the first large-scale cross-sectional survey investigating the 
prevalence and characteristics of primary care outpatients being risk of deteriorating and dying 
according to the SPICT™. 
The first important finding was that 17.3% of primary care outpatients over 65 years old were 
at risk of deteriorating and dying. This was a much higher prevalence than that shown by a 
previous smaller study, in which the prevalence was 9.2% according to the SPICT™24. One 
possible reason for this difference was that our study was conducted at 17 clinics and enrolled 
the patients of 22 GPs, while the previous study was confined to a single clinic with one GP. 
Thus, our results seem to be more reliable with regard to the prevalence of patients in primary 
care who are at risk of deteriorating and dying. In addition, our prevalence was about twice that 
determined by a cross-sectional population-based study conducted in Spain, which identified 
8.0% of patients over 65 years old with palliative care needs by using the NECPAL25. The 
NECPAL-positive patients were defined as positive for the “surprise question” (“I would not be 
surprised if this patient were to die in the next 12 months.”) and had at least one general or 
clinical indicator. Taken together with our result, it seems that a certain proportion of primary 
care outpatients are at risk of deteriorating and dying regardless of their estimated survival time.  
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The second important finding was that outpatients with dementia/frailty, neurological disease, 
cancer, and kidney disease had a significantly elevated risk of deteriorating and dying, while 
patients with other specific diseases did not. This finding suggests that outpatients over 65 years 
old with these diseases should be carefully assessed for the risk of deteriorating and dying. 
However, SPICT™ cannot identify patients with a risk of deteriorating cognitive function, 
although it evaluates the symptoms and behavioral disorders of dementia patients. Therefore, 
our finding that 67.9% of patients with dementia are at risk of deteriorating and dying requires 
careful interpretation. In the future, there is a need for a method that can evaluate the risk of 
deteriorating the cognitive function of dementia patients. 
With respect to reviewing current treatment and care, primary care outpatients with 
dementia/frailty, neurological disease, cancer, and kidney disease could be regarded as a target 
population for active communication about the goals of care, such as “Jumpstart-Tips 
intervention”26. However, GPs often feel that they lack sufficient knowledge, skills, and 
experience to talk about existential needs, and may not actively ask about 
non-physical/disease-related care needs27. Thus, to improve the quality of active communication 
about goals of care, it is important to identify the multidimensional needs of patients and the 
kinds of conversations that occur among patients at risk of deteriorating and dying, family 
members, and GPs28.  
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The third important finding was that almost half of the patients who were at risk of 
deteriorating and dying were not using a care service. This result implies that many outpatients 
at risk were not receiving optimal multidisciplinary care, which would be a barrier to initiating 
end-of-life discussions to achieve the care goals of patients. Thus, it seems important to 
implement systematic evaluation methods for identifying patients at risk and promoting 
interprofessional collaboration in primary care29, such as the Gold Standards Framework in the 
United Kingdom30. 
 
It is noteworthy that only 3% of the patients who were at risk of deteriorating and dying used 
specialized palliative care. A retrospective study performed in the UK revealed that 30% of 
primary care patients were referred to specialized palliative care before death, although referral 
tended to be late and the median time until death after referral was only 4.9 weeks2. Since our 
study was cross-sectional, it is difficult to compare the frequency of referral to specialized 
palliative care. Thus, it would be worthwhile examining the level of palliative care delivered or 
offered in Japanese primary care practice in the future. 
 
This study had several limitations. First, we only enrolled patients over 65 years old who 
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visited each clinic on a day selected in advance. Therefore, we only assessed part of the patient 
population who may be at risk of deteriorating and dying in each clinic. However, we 
minimized the influence of this methodology on the results by registering multiple doctors at 
multiple facilities. We consider that this approach is the most feasible for obtaining evidence in 
the primary care setting, although there is unavoidable sample bias. Second, our study was only 
carried out in Japan, although it was a multicenter investigation. Therefore, caution is needed 
when interpreting the results, which might be influenced by the Japanese health care system and 
cultural background. Third, observer bias might exist because assessment was conducted by the 
GPs of the patients. However, the SPICT™ was developed for assessment of patients by care 
team staff based on clinical indicators12. Therefore, observer bias should only have a small 
influence on the results. 
 In conclusion, among primary care outpatients over 65 years old in Japan, 17.3% were at risk 
of deteriorating and dying regardless of their estimated survival time, and almost half of those 
patients were not using a care service. To organize appropriate care to achieve each patient’s 
care goals, it is important to determine what multidimensional needs exist and to implement a 
systematic approach for promotion of interprofessional collaboration in primary care. 
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Table 1 Patient background factors and characteristics (n=382) 
 
 
n % 
 Age (mean ± standard deviation) 77.4 ± 7.9 
 
 Sex 
 
 
   Male 141 36.9 
   Female 241 63.1 
 Living situation 
 
 
At home with family 298 78.0 
At home alone 59 15.4 
Care facility 8 2.1 
 Main underlying disease 
 
 
Hypertension 122 31.9 
Dementia/ frailty 58 15.2 
Cardiovascular disease (not hypertension) 38 9.9 
Diabetes 30 7.9 
Hyperlipidemia 19 5.0 
Neurological disease 18 4.7 
Cancer 14 3.7 
Respiratory disease 13 3.4 
Musculoskeletal disease 8 2.1 
Mental disease 6 1.6 
Gastroesophageal reflux disease 6 1.6 
Kidney disease 5 1.3 
Liver disease 3 0.8 
Others 42 11.0 
 Charlson Comorbidity Index score  
 
 
0 301 78.8 
1 35 9.2 
2 23 6.0 
3 3 0.8 
4 4 1.0 
5 1 0.3 
6 1 0.3 
7 2 0.5 
 Palliative Performance Scale 
 
 
100 202 52.9 
90 51 13.4 
80 49 12.8 
70 20 5.2 
60 33 8.6 
50 22 5.8 
40 5 1.3 
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 Level of care need 
 
 
no certified care need 290 75.9 
Support need level 1 8 2.1 
Support need level 2 11 2.9 
Care need level 1 13 3.4 
Care need level 2 14 3.7 
Care need level 3 9 2.4 
Care need level 4 1 0.3 
Care need level 5 1 0.3 
 Current care services 
 
 
No care service 311 81.4 
One or more care services 71 18.6 
 Type of care service (Multiple answers) 
 
 
home nursing 11 2.9 
home help service 16 4.2 
home pharmacist 1 0.3 
day care/day service 54 14.1 
specialized palliative care service 2 0.5 
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Table 2 Prevalence of patients at risk of deteriorating and dying 
  
 
n % 
General clinical risk of deteriorating health (n=382) 
  
Two or more unplanned hospital admissions in the past 6 months 1 0.3 
Performance status is poor or deteriorating, with limited reversibility 24 6.3 
Dependent on others for care due to physical and/or mental health problems 26 6.8 
Significant weight loss over the past 3-6 months, and/ or a low body mass index 18 4.7 
Persistent symptoms despite optimal treatment of underlying condition(s) 16 4.2 
Person or family ask for palliative care, treatment withdrawal/limitation, or a focus on quality of life 97 25.4 
Specific disease-specific risk for deterioration of specific conditions 
  
 Cancer (n=14) 
  
Functional ability deteriorating due to progressive cancer 3 21.4 
Too frail for cancer treatment or treatment is for symptom control 2 14.3 
 Dementia/ frailty (n=56) 
  
Unable to dress, walk or eat without help 12 21.4 
Eating and drinking less; swallowing difficulties 9 16.1 
Urinary and faecal incontinence 13 23.2 
No longer able to communicate using verbal language; little social interaction 23 41.1 
Fractured femur; multiple falls 10 17.9 
Recurrent febrile episodes or infections; aspiration pneumonia 2 3.6 
 Neurological disease (n=18) 
  
Progressive deterioration in physical and/or cognitive function despite optimal therapy 7 38.9 
Speech problems with increasing difficulty communicating and/or progressive swallowing difficulties 2 11.1 
Recurrent aspiration pneumonia; breathless or respiratory failure 1 5.6 
 Cardiovascular disease (n=38) 
  
NYHA Class III/IV heart failure, or extensive, untreatable coronary artery disease with: breathlessness or chest pain at rest or on minimal 
exertion 
4 10.5 
Severe, inoperable peripheral vascular disease 0 0.0 
 Respiratory disease (n=13) 
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Severe chronic lung disease with: breathlessness at rest or on minimal exertion between exacerbations 2 15.4 
Needs long term oxygen therapy 1 7.7 
Has needed ventilation for respiratory failure or ventilation is contraindicated 0 0.0 
 Kidney disease (n=5) 
  
Stage 4 or 5 chronic kidney disease (eGFR < 30ml/min) with deteriorating health 3 60.0 
Kidney failure complicating other life limiting conditions or treatments 3 60.0 
Stopping dialysis 0 0.0 
 Liver disease (n=3) 
  
Advanced cirrhosis with one or more complications in past year: diuretic resistant ascites 0 0.0 
Advanced cirrhosis with one or more complications in past year: hepatic encephalopathy 0 0.0 
Advanced cirrhosis with one or more complications in past year: hepatorenal syndrome 0 0.0 
Advanced cirrhosis with one or more complications in past year: bacterial peritonitis 0 0.0 
Advanced cirrhosis with one or more complications in past year: recurrent variceal bleeds 0 0.0 
Liver transplantation is contraindicated 2 66.7 
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Table 3 Characteristics of patients with or without an elevated risk of deteriorating and dying 
  
      
 
With two or more 
general indicators or one 
or more disease-specific 
indicators (n=66) 
Without two or more 
general indicators or one 
or more disease-specific 
indicators (n=316) 
 
 
n % n % p value 
 Age (mean ± standard deviation) 84.6 ± 7.9 
 
75.9 ± 7.0 
 
<0.001 
 Sex 
    
0.858 
   Male 25 37.9 116 36.7 
 
   Female 41 62.1 200 63.3 
 
 Living situation 
    
0.001* 
At home with family 47 71.2 251 79.4 
 
At home alone 11 16.7 48 15.2 
 
Care facility 6 9.1 2 0.6 
 
 Main underlying disease 
     
Dementia/ frailty 38 57.6 20 6.3 <0.001 
Cardiovascular disease (not hypertension) 5 7.6 33 10.4 0.479 
Neurological disease 7 10.6 11 3.5 0.022* 
Cancer 6 9.1 8 2.5 0.020* 
Respiratory disease 2 3.0 11 3.5 0.272* 
Kidney disease 3 4.5 2 0.6 0.038* 
Liver disease 2 3.0 1 0.3 0.078* 
Others 3 4.5 230 72.8 <0.001 
 Charlson Comorbidity Index score  
    
<0.001* 
0 40 60.6 261 82.6 
 
1-4 19 28.8 46 14.6 
 
≥5 3 4.5 1 0.3 
 
 Level of care need 
    
<0.001 
no certified care need 24 36.4 266 84.2 
 
any level of certified care need 38 57.6 34 10.8 
 
 Current care services 
    
<0.001 
No care service 31 47.0 279 88.3 
 
One or more care services 35 53.0 36 11.4 
 
 Types of care service (Multiple answers) 
     
home nursing 9 13.6 2 0.6 <0.001* 
home help service 11 16.7 5 1.6 <0.001* 
home pharmacist 1 1.5 0 0.0 0.173 
day care/day service 26 39.4 28 8.9 <0.001 
specialized palliative care service 2 3.0 0 0.0 0.030* 
*Fisher’s exact test 
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Appendix 1. Supportive and Palliative CareIndicators Tool (SPICT™), April 2015 
   
         
Look for two or more general indicators of deteriorating health     
• Performance status is poor or deteriorating (in bed or a chair for ≥50% of the day); reversibility is limited  
• Dependent on others for most care needs due to physical or mental health problems 
  
• Two or more unplanned hospital admissions in the past 6 months 
    
• Significant weight loss (5–10%) over the past 3–6 months or a low body mass index 
  
• Persistent, troublesome symptoms despite optimal treatment of underlying condition(s)  
  
• Patient asks for supportive and palliative care or treatment withdrawal    
         
Look for any clinical indicators of one or more advanced conditions     
Cancer 
        
• Functional ability deteriorating due to progressive metastatic cancer 
    
• Too frail for oncology treatment or treatment is for symptom control  
    
Dementia/frailty 
       
• Unable to dress, walk, or eat without help 
      
• Eating and drinking less or swallowing difficulties 
     
• Urinary and faecal incontinence 
      
• No longer able to communicate using verbal language or little social interaction 
   
• Femur fracture or multiple falls 
      
• Recurrent febrile episodes or infections, or aspiration pneumonia  
    
Neurological diseases 
       
• Progressive deterioration in physical or cognitive function despite optimal therapy 
  
• Speech problems with increasing difficulty communicating or progressive swallowing difficulties 
  
• Recurrent aspiration pneumonia, breathlessness, or respiratory failure 
    
Heart/vascular disease  
       
• NYHA* Class III/IV heart failure or extensive untreatable coronary artery disease with 
breathlessness or chest pain at rest or on minimal exertion    
• Severe inoperable peripheral vascular disease 
     
Respiratory disease 
       
• Severe chronic lung disease with breathlessness at rest or on minimal 
exertion between exacerbations       
• Needs long-term oxygen therapy 
      
• Has needed ventilation for respiratory failure or ventilation is contraindicated 
   
Kidney disease  
       
• Stage 4 or 5 chronic kidney disease (eGFR#< 30 ml/min) with deteriorating health  
   
• Kidney failure complicating other life-limiting conditions or treatments  
    
• Discontinuation of dialysis 
       
Liver disease  
       
• Advanced cirrhosis with one or more complications in the past year: 
    
 Diuretic resistant ascites  
       
 Hepatic encephalopathy  
       
 Hepatorenal syndrome 
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 Bacterial peritonitis 
       
 Recurrent variceal bleeding 
       
• Liver transplantation is contraindicated       
* NYHA: New York Heart Association      
#eGFR: estimated glomerular filtration rate      
      
 
